IMMUNOHISTOCHEMISTRY FLI-1 Test
Test Name: IMMUNOHISTOCHEMISTRY FLI-1 Test
Components: FLI-1 protein
Price: 510.0 AED
Sample Condition: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Report Delivery: Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex: 7 days
Method: Immunohistochemistry
Test Type: Cancer
Doctor: Oncologist
Test Department: HISTOLOGY
Pre Test Information: Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Test Details
The FLI-1 test is an immunohistochemistry (IHC) test used to detect the presence of FLI-1 protein in tissues. FLI-1 is a transcription factor that plays a crucial role in the development of blood vessels and hematopoietic cells.
The FLI-1 test is primarily used in the diagnosis of certain types of tumors, such as Ewing’s sarcoma, primitive neuroectodermal tumors, and angiosarcoma. These tumors often show overexpression of FLI-1 protein, which can be detected through IHC.
During the FLI-1 test, a tissue sample (usually obtained through a biopsy) is treated with specific antibodies that bind to FLI-1 protein. These antibodies are usually labeled with a dye or an enzyme, which allows for visualization of the protein under a microscope. If FLI-1 protein is present in the tissue, it will bind to the antibodies and appear as a positive staining pattern.
The FLI-1 test can provide important diagnostic and prognostic information for patients with certain types of tumors. It can help differentiate between different tumor types and guide treatment decisions. However, it is important to note that the FLI-1 test is just one component of a comprehensive diagnostic workup and should be interpreted in conjunction with other clinical and pathological findings.
| Test Name | IMMUNOHISTOCHEMISTRY FLI-1 Test |
|---|---|
| Components | |
| Price | 510.0 AED |
| Sample Condition | Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
| Report Delivery | Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex : 7 days |
| Method | Immunohistochemistry |
| Test type | Cancer |
| Doctor | Oncologist |
| Test Department: | HISTOLOGY |
| Pre Test Information | Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
| Test Details |
The FLI-1 test is an immunohistochemistry (IHC) test used to detect the presence of FLI-1 protein in tissues. FLI-1 is a transcription factor that plays a crucial role in the development of blood vessels and hematopoietic cells. The FLI-1 test is primarily used in the diagnosis of certain types of tumors, such as Ewing’s sarcoma, primitive neuroectodermal tumors, and angiosarcoma. These tumors often show overexpression of FLI-1 protein, which can be detected through IHC. During the FLI-1 test, a tissue sample (usually obtained through a biopsy) is treated with specific antibodies that bind to FLI-1 protein. These antibodies are usually labeled with a dye or an enzyme, which allows for visualization of the protein under a microscope. If FLI-1 protein is present in the tissue, it will bind to the antibodies and appear as a positive staining pattern. The FLI-1 test can provide important diagnostic and prognostic information for patients with certain types of tumors. It can help differentiate between different tumor types and guide treatment decisions. However, it is important to note that the FLI-1 test is just one component of a comprehensive diagnostic workup and should be interpreted in conjunction with other clinical and pathological findings. |
